Kathmere Capital Management, LLC Novartis Ag Transaction History
Kathmere Capital Management, LLC
- $1.11 Billion
- Q1 2025
A detailed history of Kathmere Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 18,742 shares of NVS stock, worth $2.17 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
18,742
Previous 12,954
44.68%
Holding current value
$2.17 Million
Previous $1.26 Million
65.79%
% of portfolio
0.19%
Previous 0.12%
Shares
15 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...